Price $35.82 |
Market Cap
4.17B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
6.36
|
P/S
10.29
|
Dividend %
-
|
|
P/CF
25.7
|
P/FCF
-
|
Op. Cash Flow
16.9K
|
FCF
0.0
|
|
Op. Margin
-4.80%
|
Net Margin
-1.30%
|
ROE
-1.00%
|
ROI
2.70%
|
|
ROA
-0.70%
|
EPS Growth
-320.90%
|
Current Ratio
4.5
|
Debt/Equity
18.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China SXT Pharmaceuticals Inc (SXTC) | $0.25 | - | - | 19.6M | Strong Buy |
| Dynasil Corporation of America (DYSL) | $0.84 | - | - | 13.5M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $20.36 | - | 0.10% | 1.1B | Strong Buy |
| ImmuCell Corporation (ICCC) | $5.39 | - | - | 38.6M | Strong Buy |
| Aerpio Pharmaceuticals Inc (ARPO) | $1.41 | - | - | 58.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
